P Egermayer. Show Affiliations »
Abstract
Entities: Chemical
Mesh: See more » Anticoagulants/adverse effectsAnticoagulants/therapeutic useFibrinolysis/drug effectsHeparin/therapeutic useHumansPulmonary Embolism/drug therapyPulmonary Embolism/mortalityPulmonary Embolism/prevention & controlRecurrenceRisk
Substances: See more » AnticoagulantsHeparin
Year: 1981 PMID: 7288810 PMCID: PMC1438862 DOI: 10.1177/014107688107400911
Source DB: PubMed Journal: J R Soc Med ISSN: 0141-0768 Impact factor: 18.000